期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌MR动态增强扫描定量分析及其临床应用 被引量：9

Quantitative dynamic contrast-enhanced MRI : clinical application in breast cancer
下载PDF
导出
摘要 对于乳腺癌的检出,乳腺MR成像被认为是一种具有高敏感性和较高特异性的检查方式。动态增强MRI定量分析可以通过Ktrans、kep、ve等多种参数的应用,量化评价肿瘤组织的血管内皮通透性和血流量。其较半定量分析能更为准确、客观地诊断肿瘤的良恶性及评价治疗疗效。就应用动态增强MRI定量分析乳腺癌的现状及目前所存在的问题作一综述。
作者 张薇薇 许乙凯
机构地区 南方医科大学南方医院影像中心
出处 《国际医学放射学杂志》 2012年第3期240-243,共4页 International Journal of Medical Radiology
关键词 乳腺癌 磁共振成像 定量 动态增强 诊断 新辅助化疗
分类号 R445.2 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献31

  • 1Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J ]. Radiology,2004, 233: 830-849.
  • 2Liberman L. Breast cancer screening with MRI--what are the data for patients at'high risk [J ]. N Engl J Med,2004, 351: 497-500.
  • 3Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium [J ]. J Magn Reson Imaging,1999, 10: 903-907.
  • 4Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model [J]. Magn Reson Med,1995, 33: 564-568.
  • 5Schneider BP, Miller KD. Angiogenesis of breast cancer [J ]. J Clin Oncol, 2005, 23: 1782-1790.
  • 6Cron GO, Kelcz F, Santyr GE. Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T~ measurements [J ]. Magn Reson Med,2004, 51: 1066-1070.
  • 7Moon M, Cornfeld D, Weinreb J. Dynamic contrast-enhanced breast MR imaging[J]. Magn Reson Imaging Clin N Am, 2009, 17: 351- 362.
  • 8Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging [J ]. Magn Reson Med, 1996, 36: 225- 231.
  • 9Simpson NE, Evelhoch JL. Deuterium NMR tissue perfusion measu- rements using the tracer uptake approach: lI . Comparison with mierospheres in tumors [J ]. Magn Resoo Med, 1999, 42: 240-247.
  • 10T Simpson NE, He Z, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods [J ]. Magn Reson Med,1999, 42: 42-52.

二级参考文献14

  • 1张嵘,李勇,任俊杰,梁碧玲,文艳玲,李海刚.乳腺叶状瘤的影像诊断[J].中华放射学杂志,2004,38(7):717-720. 被引量：23
  • 2Sinha S,Sinha U.Recent advances in breast MRI and MRS.NMB Biomed,2009,22:3-16.
  • 3Murase K.Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging.Magn Reson Med,2004,51:858-862.
  • 4Yankeelov TE,Lepage M,Chakravarthy A,et al.Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer:initial results.Magn Reson Imaging,2007,25:1-13.
  • 5Tofts PS,Brix G,Buckley DL,et al.Estimating kinetic parameters from dynamic contrast-enhanced T1 -weighted MRI of a diffusable tracer:standardized quantities and symbols.J Magn Rein Imaging,1999,10:223-232.
  • 6Tavassoli FA,Devillee P.WHO classification of tumours pathology & genetics:tumours of the breast and female genital organs.Lyon:IARC Press,2003:9-112.
  • 7Huang W,Li X,Morris EA,et al.The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.Proc Natl Acad Sci USA,2008,105:17943-17948.
  • 8Barrett T,Brechbiel M,Bernardo M,et aL MRI of tumor angiogenesis.J Magn Reson Imaging,2007,26:235-249.
  • 9Toffs PS.Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J Magn Reson Imaging,1997,7:91-101.
  • 10Wang Y,Huang W,Panicek DM.Feasibility of using limitedpopulation-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data.Magn Reson Med,2008,59:1183-1189.

共引文献82

同被引文献76

  • 1顾雅佳,冯晓源,唐峰,彭卫军,毛健,杨文涛.乳腺肿瘤的MRI扩散特征及参数选定[J].中华放射学杂志,2007,41(5):451-456. 被引量：45
  • 2El Khouli RH, Macura KJ, Kamel IR, et al. 3-T dynamic con-trast-enhanced MRI of the breast: Pharmacokinetic parametersversus conventional kinetic curve analysis. AJR Am J Roentgen-ol, 2011,197(.6):1498-1505.
  • 3Yu Y, Jiang Q, Miao Y, et al. , Quantitative analysis of clinicaldynamic contrast-enhanced MR imaging for evaluating treatmentresponse in human breast cancer. Radiology, 2010,257 (1) : 47-55.
  • 4徐慧,贾文霄,周梅.三阴性乳腺癌MR征象与病理学表现的相关性分析.中国医学影像技术,2010,26(增刊):31-34.
  • 5Lee SH, Cho N, Kim SJ, et al. Correlation between high resolu-tion dynamic MR features and prognostic factors in breast cancer.Korean J Radiol, 2008,9(1) :10-18.
  • 6Tofts PS, BrixG,Buckley DL, et al. Estimating kinetic parame-ters from dynamic contrast-enhanced T(l)-weighted MRI of a dif-fusable tracer: Standardized quantities and symbols. J Magn Re-son Imaging, 1999,10(3) :223-232.
  • 7Hammond ME, Hayes DF, Dowsett M, et al. American societyof clinical oncology/college of American pathologists guidelinerecommendations for immunohistochemical testing of estrogen andprogesterone receptors in breast cancer (unabridged version).Arch Pathol Lab Med, 2010,134(7) :e48-e72.
  • 8Li SP, Taylor NJ, Makris A, et al. Primary human breast adeno-carcinoma: Imaging and histologic correlates of intrinsic suscepti-bility-weighted MR imaging before and during chemotherapy. Ra-diology, 2010,257(3):643-652.
  • 9Pickles MD, Manton DJ, Lowry M, et al. Prognostic value ofpre-treatment DCE-MRI parameters in predicting disease free andoverall survival for breast cancer patients undergoing neoadjuvantchemotherapy. Eur J Radiol, 2009,71(3) :498-505.
  • 10Linderholm BK, Heilborg H, Johansson U, et al. Significantlyhigher levels of vascular endothelial growth factor (VEGF) andshorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol, 2009, 20( 10) : 1639-1646.

引证文献9

二级引证文献73

国际医学放射学杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部